| 1 | 12177586 | Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. | Int Clin Psychopharmacol | 2002 Sep |
1 |
| 2 | 12750432 | The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. | J Pharmacol Exp Ther | 2003 Sep |
2 |
| 3 | 15380370 | Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. | Neuropharmacology | 2004 Sep |
1 |
| 4 | 16225556 | Newer treatment studies for bipolar depression. | Bipolar Disord | 2005 |
1 |
| 5 | 16436935 | Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. | Int Clin Psychopharmacol | 2006 Feb |
6 |
| 6 | 16687314 | Therapeutic potential of melatonin ligands. | Chronobiol Int | 2006 |
2 |
| 7 | 16918076 | Homology modelling of the serotoninergic 5-HT2c receptor. | J Enzyme Inhib Med Chem | 2006 Jun |
1 |
| 8 | 17140278 | Agomelatine: a preliminary review of a new antidepressant. | CNS Drugs | 2006 |
1 |
| 9 | 17477888 | Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. | Int J Neuropsychopharmacol | 2007 Oct |
1 |
| 10 | 17917562 | Evidence of agomelatine's antidepressant efficacy: the key points. | Int Clin Psychopharmacol | 2007 Oct |
4 |
| 11 | 17917563 | High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder. | Int Clin Psychopharmacol | 2007 Oct |
1 |
| 12 | 18583104 | Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system. | Eur Psychiatry | 2008 Sep |
3 |
| 13 | 18706130 | The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats. | Int J Neuropsychopharmacol | 2009 Apr |
2 |
| 14 | 19571795 | Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. | Neuropsychopharmacology | 2009 Oct |
5 |
| 15 | 19758108 | Agomelatine, a melatonin agonist with antidepressant properties. | Expert Opin Investig Drugs | 2009 Oct |
2 |
| 16 | 19777735 | [Agomelatine]. | Med Monatsschr Pharm | 2009 Aug |
3 |
| 17 | 19827314 | [Depression as chronobiological illness]. | Neuropsychopharmacol Hung | 2009 Jun |
2 |
| 18 | 19966905 | Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults. | Neuropsychiatr Dis Treat | 2009 |
1 |
| 19 | 20109111 | Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration. | World J Biol Psychiatry | 2010 Mar |
10 |
| 20 | 20236141 | The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats. | CNS Neurosci Ther | 2010 Aug |
2 |
| 21 | 20525261 | Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways. | BMC Neurosci | 2010 Jun 3 |
1 |
| 22 | 20577266 | Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. | Nat Rev Drug Discov | 2010 Aug |
1 |
| 23 | 20685215 | Effect of agomelatine and its interaction with the daily corticosterone rhythm on progenitor cell proliferation in the dentate gyrus of the adult rat. | Neuropharmacology | 2010 Nov |
1 |
| 24 | 20874703 | The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine. | CNS Neurol Disord Drug Targets | 2011 Feb |
1 |
| 25 | 21181122 | Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine. | Psychopharmacology (Berl) | 2011 May |
4 |
| 26 | 21453740 | Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics? | Prog Neuropsychopharmacol Biol Psychiatry | 2011 Jun 1 |
4 |
| 27 | 21476953 | Circadian rhythms, melatonin and depression. | Curr Pharm Des | 2011 |
1 |
| 28 | 21503609 | Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. | Psychopharmacology (Berl) | 2011 Oct |
1 |
| 29 | 21688292 | Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain. | J Neurosci Res | 2011 Oct |
5 |
| 30 | 21830835 | A benefit-risk assessment of agomelatine in the treatment of major depression. | Drug Saf | 2011 Sep 1 |
1 |
| 31 | 21916789 | Agomelatine for the treatment of major depressive disorder. | Expert Opin Pharmacother | 2011 Oct |
5 |
| 32 | 21925847 | The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure. | Eur Neuropsychopharmacol | 2012 Mar |
1 |
| 33 | 21999473 | Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. | World J Biol Psychiatry | 2011 Dec |
4 |
| 34 | 22040921 | Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006. | Eur J Pharmacol | 2012 Jan 5 |
1 |
| 35 | 22102540 | The effects of agomelatine on sexual function in depressed patients and healthy volunteers. | Hum Psychopharmacol | 2011 Dec |
2 |
| 36 | 22160164 | Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC. | Psychopharmacology (Berl) | 2012 Jun |
1 |
| 37 | 22191083 | Agomelatine: a novel antidepressant. | Innov Clin Neurosci | 2011 Nov |
1 |
| 38 | 22335516 | Emerging targets for the pharmacological treatment of depression: focus on melatonergic system. | Curr Med Chem | 2012 |
4 |
| 39 | 22647752 | The antidepressant agomelatine inhibits stress-mediated changes in amino acid efflux in the rat hippocampus and amygdala. | Brain Res | 2012 Jul 23 |
1 |
| 40 | 22867907 | Synergistic mechanisms involved in the antidepressant effects of agomelatine. | Eur Neuropsychopharmacol | 2012 |
2 |
| 41 | 23262445 | Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands. | Molecules | 2012 Dec 24 |
2 |
| 42 | 23530731 | Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review. | World J Biol Psychiatry | 2013 Aug |
2 |
| 43 | 23584358 | Agomelatine: an antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats. | Hum Exp Toxicol | 2013 Aug |
2 |
| 44 | 23650464 | Mood disorders, circadian rhythms, melatonin and melatonin agonists. | J Cent Nerv Syst Dis | 2012 |
1 |
| 45 | 23663281 | Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece. | BMC Health Serv Res | 2013 May 10 |
1 |
| 46 | 23719026 | On 'polypharmacy' and multi-target agents, complementary strategies for improving the treatment of depression: a comparative appraisal. | Int J Neuropsychopharmacol | 2014 Jul |
2 |
| 47 | 23768699 | Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam. | Kaohsiung J Med Sci | 2013 Jul |
3 |
| 48 | 23801192 | Effects of agomelatine on oxidative stress in the brain of mice after chemically induced seizures. | Cell Mol Neurobiol | 2013 Aug |
1 |
| 49 | 23983944 | Agomelatine in unipolar depression in clinical practice: a retrospective chart review. | Ther Adv Psychopharmacol | 2011 Dec |
4 |
| 50 | 24031039 | Synthesis and pharmacological evaluation of a series of the agomelatine analogues as melatonin MT1 /MT2 agonist and 5-HT2C antagonist. | ChemMedChem | 2013 Nov |
3 |